BCRX vs CAPR Stock Comparison

BCRX currently leads CAPR in this stock comparison, with AIQ scores of 59 vs 38. The clearest difference is risk resilience.

Market data as of Nov 15, 2026 market close· AIQ score gap 21 points
BCRX
Healthcare
vs
CAPR
Healthcare
BCRX
BioCryst Pharmaceuticals, Inc.
Leads
Price
$7.61
Day move
-0.91%
AIQ Score
59/100
Best edge
Risk Resilience
Sector
Healthcare
CAPR
Capricor Therapeutics, Inc.
Price
$9.53
Day move
-6.93%
AIQ Score
38/100
Best edge
Balanced
Sector
Healthcare

What is the main difference between BCRX and CAPR?

BCRX leads the current stock comparison as BioCryst Pharmaceuticals, Inc., with the clearest separation coming from risk resilience and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

BioCryst Pharmaceuticals, Inc. vs Capricor Therapeutics, Inc.

Data as of Nov 15, 2026· market close· Healthcare· Coverage 63/66 fields· High confidence
AIQ VerdictCompetitiveAIQ Comparison Conviction 8/10

BCRX leads

BCRX leads by 21 AIQ points, primarily on Risk Resilience and Quality, but the lead has narrowed from 34 points over 30 sessions. Wall Street currently favors CAPR on target upside.

Competitive: 3 of 5 evidence groups support BCRX, and its lead is narrowing.

Evidence agreement: 3 of 5Comparison trend: Weakening
BCRX

BioCryst Pharmaceuticals, Inc.

Leads
AIQ Score
59/100
AIQ Edge Score
6/10
CAPR

Capricor Therapeutics, Inc.

AIQ Score
38/100
AIQ Edge Score
6/10

The Algovestiq AIQ Score currently favors BCRX over CAPR, 59 versus 38 as of Nov 15, 2026. BCRX's advantage is driven primarily by stronger risk resilience and quality. BCRX also shows the weaker technical structure relative to its 50-day moving average, though analyst target upside currently favors CAPR. 3 of 5 covered evidence groups favor BCRX today, and the comparison is rated Competitive on stability: the leader's advantage has been narrowing. BCRX lead: Weakening — the AIQ differential moved from 34 to 21 points over 30 sessions.

Compare BioCryst Pharmaceuticals, Inc. and Capricor Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

BCRX
-36.6%
CAPR
+182.0%

Price return comparison

Growth of $10,000, price only

BCRX $6,336 · CAPR $28,195

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare BCRX and CAPR against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

BCRX advantage
0
CAPR advantage
  • Risk Resilience55 vs 16
    BCRX +39
  • Quality64 vs 40
    BCRX +24
  • Momentum42 vs 45
    Even

3 of 5 evidence groups favor BCRX. BCRX’s edge is concentrated in risk resilience and quality.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

BCRX0 AIQ

Largest factor move: Quality +1, not enough on its own to move the overall score.

No signal started or stopped since the prior session; its 4 active signals are unchanged.

CAPR-3 AIQ

Largest factor move: Quality -7

No signal started or stopped since the prior session; its 6 active signals are unchanged.

BCRX's lead widened by 3 AIQ points in the latest session.

Deeper signal detail for each name lives on its own signals page — BCRX and CAPR both carry a full feed there.

The central trade-off

BCRX (BioCryst Pharmaceuticals, Inc.): the stronger current systematic profile, led by risk resilience and quality.

CAPR (Capricor Therapeutics, Inc.): the counter-case, on analyst expectations — but at materially higher volatility, 148.3% against 45.2%.

The AIQ Score and Wall Street therefore point in different directions on this pair.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

BCRX

BCRX on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

CAPR

CAPR on combined revenue and EPS growth.

Value

Even

The two are level on Value.

Momentum

Even

The two are level on Momentum.

Lower downside

BCRX

BCRX on Risk Resilience, by 39 points.

Analyst upside

CAPR

CAPR on implied upside to the consensus price target.

AIQ vs Wall Street

The model and the Street disagree here: AIQ favors BCRX, analyst targets favor CAPR. That disagreement is the most useful thing on this page.

MeasureBCRXCAPRNote
Implied upside to target+44.5%+141.3%CAPR has more room
Target dispersion0%+17.4%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1111Higher coverage generally improves confidence

The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 5 covered evidence groups favor BCRX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreBCRX59 vs 38
FundamentalsEvenEPS growth -51.6% vs -4.3%; TTM ROE -9.5% vs -20.3%
ValuationNot coveredNot covered
TechnicalsBCRXPrice vs 50-day -7.6% vs 17.6%; vs 200-day -13.5% vs -52.4%
Risk ResilienceBCRXRisk Resilience 55 vs 16
Analyst expectationsCAPRTarget upside 44.5% vs 141.3%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BCRX and CAPR and are excluded from the count.

AIQ Decision Stability

Competitive

The two are close enough that your objective, not the score, should decide.

  • The AIQ gap is wide at 21 points. (supports the conclusion holding)
  • The leader's advantage has been narrowing. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BCRX.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

BCRX lead: Weakening — the AIQ differential moved from 34 to 21 points over 30 sessions.

May 27BCRX leads above the line · CAPR leads belowNov 13
Today
BCRX +21
59 vs 38
7 sessions ago
BCRX +22
62 vs 40
30 sessions ago
BCRX +34
60 vs 26
90 sessions ago
BCRX +43
71 vs 28

The lead has not changed hands in this window.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

BCRX

0 bullish / 2 bearish / 2 neutral

Only BCRX

  • ADX Trend Weakening — neutral, trend, medium horizon
  • Downtrend Structure Active — bearish, trend, long horizon
CAPRConflicted

1 bullish / 3 bearish / 2 neutral, conflicted

Only CAPR

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • Beta Spike Warning — bearish, risk_regime, long horizon
  • RSI Bearish Divergence — bearish, momentum, medium horizon
  • TRIX Bullish Signal — bullish, momentum, short horizon

Both carry 2 more signals that do not separate them: Death Cross Active, ATR Expansion - Breakout Mode.

CAPR is conflicted, so the timing case there is weaker than the score alone suggests.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

BCRXNo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.91%, AIQ 0 points).

CAPRConfirmed weakness

Price and the AIQ Score both moved down over the latest session (price -6.93%, AIQ -3 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1CAPR closes the Risk Resilience gap — currently 39 points behind, the largest single contributor to BCRX's edge.
  2. 2CAPR's Death Cross Active resolves — a bearish trend rule currently active against it.
  3. 3BCRX starts generating bearish momentum or trend signals.
  4. 4The narrowing continues — the lead has already given back 13 points over 30 sessions, and a further 21-point move would eliminate BCRX's advantage entirely.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

Split
MetricBCRXCAPR
Revenue growth (YoY)-17.4%0%
EPS growth (YoY)-51.6%-4.3%
Gross margin25.3%0%
Operating margin-30.1%0%
Return on equity (TTM)-9.5%-20.3%
Debt to equity-2.080.44

Performance

CAPR leads 4 of 6 windows
MetricBCRXCAPR
1 week (5 sessions)-1%5.9%
1 month (20 sessions)-2.3%42%
3 months (63 sessions)-23.4%27.9%
6 months (126 sessions)-15.6%-68%
Year to date-2.4%-67%
1 year (252 sessions)6%53.7%

Technicals

BCRX has the stronger structure
MetricBCRXCAPR
RSI (14)40.757.2
ADX (14)15.230.4
Price vs 50-day-7.6%17.6%
Price vs 200-day-13.5%-52.4%
Volatility (1M, annualized)45.2%148.3%

Risk

BCRX is the more resilient
MetricBCRXCAPR
Beta0.651.35
Sharpe ratio0.360.93
Sortino ratio0.563.85
Max drawdown-32.2%-89.1%
Current drawdown-31.5%-73%
Annualized volatility48.1%395.2%
Value at risk (95%)-4.1%-8.7%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, BCRX or CAPR?

On the Algovestiq AIQ Score, BCRX is the stronger of the two as of Nov 15, 2026, scoring 59 against CAPR's 38. The edge comes from risk resilience and quality. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is BCRX or CAPR the better buy right now?

BCRX carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Competitive — 3 of 5 covered evidence groups agree. A Competitive rating means the two are close enough that your objective, not the score, should decide.

Why does the AIQ Score favor BCRX over CAPR?

The composite weights Quality, Value, Momentum and Risk Resilience. BCRX leads Risk Resilience by 39 points; BCRX leads Quality by 24 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, BCRX or CAPR?

Analyst price targets imply +44.5% upside for BCRX and +141.3% for CAPR, so the Street currently favors CAPR. That points the opposite way to the AIQ Score, which favors BCRX. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, BCRX or CAPR?

Neither name separates on the peer-relative Value factor. The two are level on Value. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, BCRX or CAPR?

CAPR on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, BCRX or CAPR?

The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, BCRX or CAPR?

BCRX is the more resilient of the two, so the other name carries the higher downside risk. BCRX on Risk Resilience, by 39 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is BCRX more profitable than CAPR?

BCRX leads on the comparable margin measures — gross margin 25.3% vs 0%; operating margin -30.1% vs 0%; ttm roe -9.5% vs -20.3%.

Is BCRX's lead over CAPR getting stronger or weaker?

BCRX lead: Weakening — the AIQ differential moved from 34 to 21 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has not changed hands in that window.

What would change the BCRX vs CAPR verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CAPR closes the Risk Resilience gap — currently 39 points behind, the largest single contributor to BCRX's edge; CAPR's Death Cross Active resolves — a bearish trend rule currently active against it; BCRX starts generating bearish momentum or trend signals; the narrowing continues — the lead has already given back 13 points over 30 sessions, and a further 21-point move would eliminate BCRX's advantage entirely.

What do the current signals say about BCRX and CAPR?

BCRX: 0 bullish / 2 bearish / 2 neutral. CAPR: 1 bullish / 3 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BCRX is Death Cross Active (bearish, long horizon). On CAPR it is Death Cross Active (bearish, long horizon).

Compare BCRX and CAPR with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.